We are monitoring the impact of COVID-19 on Bovine Respiratory Disease Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 847
Share on
Share on

Global Bovine Respiratory Disease Treatment Market Analysis Report - By Type of Treatment and Region - Industry Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast | 2019 - 2024

Pulished: August, 2019
ID: 847
Pages: 175

Global Bovine Respiratory Disease Treatment Market Size & Growth (2019 - 2024)

The Global Bovine Respiratory Disease Treatment Market size has been estimated at USD 44.9 million in 2019 and is projected to reach USD 124.6 million by 2024, at a CAGR of 22.4% during the forecast period 2019 - 2024.

The threat of bovine respiratory disease (BRD) has an important effect on the value of cattle in the marketplace. Bovine Respiratory Disease is the most popular and costly disease affecting the beef cattle industry. The disease which affects both lower and upper respiratory tract is referred to as BRD.

BRD is a common term for respiratory disease in cattle caused by a variety of factors. A major cause of economic losses, BRD affects the lower respiratory tract/lungs (pneumonia) or upper respiratory tract (rhinitis, tracheids, bronchitis). The key factor responsible for the disease is stress. Early detection is touted as an important key to treatment success.  Bovine respiratory disease (BRD) can be a costly expense for cattle producers. However, it can be avoided by making the use of vaccines.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Treatment Type & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.

 

This research report on the Global Bovine Respiratory Disease Treatment Market has been segmented and sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.

Bovine Respiratory Disease Treatment Market Analysis - By Treatment Type

  • Anti-Infectious Agents
    • Antibiotics           
    • Sulfas    
  • Anti-Parasiticides                 
  • Bronchodilators                    
  • Oral Rehydration Fluids                     
  • Non-Steroidal Anti-Inflammatories               
  • Mucolytics

On the basis of treatment type, Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment.

Regional Analysis:

North America leads the market due to the greater occurrence of bovine respiratory disease.  In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast.

Companies leading the Global Bovine Respiratory Disease Treatment Market profiled in the report are:

  1. Zoetis Inc.
  2. Merck & Co. Inc.
  3. Bayer Corporation
  4. Eli Lilly & Co.
  5. Merial S.A.S
  6. Boehringer Ingelheim Vetmedica
  7. Novartis Animal Health
  8. Vibrac S.A
  9. Ceva Sante Animale and Vétoquinol S.A.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       

                                                5.1.1.1 Antibiotics           

                                                5.1.1.2 Sulfas    

                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                           

                                6.2.6 France                      

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                        

                                6.3.5 South Korea                           

                                6.3.6 Australia                  

                6.4 Latin America                                            

                                6.4.1 Introduction                           

                                6.4.2 Brazil                         

                                6.4.3 Mexico                     

                                6.4.4 Argentina                

                                6.4.5 Rest of Latin America                         

                6.5 Middle East & Africa                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                        

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Bovine Respiratory Disease Treatment Market By Region, From 2019-2024 (USD Million)
  2. Global Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  3. Global Anti-Infectious Agents Market By Region, From 2019-2024 (USD Million)
  4. Global Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  5. Global Antibiotics Market By Region, From 2019-2024 (USD Million)
  6. Global Sulfas Market By Region, From 2019-2024 (USD Million)
  7. Global Anti-Parasiticides Market By Region, From 2019-2024 (USD Million)
  8. Global Bronchodilators Market By Region, From 2019-2024 (USD Million)
  9. Global Oral Rehydration Fluids Market By Region, From 2019-2024 (USD Million)
  10. Global Non-Steroidal Anti-Inflammatories Market By Region, From 2019-2024 (USD Million)
  11. Global Mucolytic Market By Region, From 2019-2024 (USD Million)
  12. North America Bovine Respiratory Disease Treatment Market By Region, From 2019-2024 (USD Million)
  13. North America Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  14. North America Anti-Infectious Agents Market By Region, From 2019-2024 (USD Million)
  15. North America Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  16. North America Antibiotics Market By Region, From 2019-2024 (USD Million)
  17. North America Sulfas Market By Region, From 2019-2024 (USD Million)
  18. North America Anti-Parasiticides Market By Region, From 2019-2024 (USD Million)
  19. North America Bronchodilators Market By Region, From 2019-2024 (USD Million)
  20. North America Oral Rehydration Fluids Market By Region, From 2019-2024 (USD Million)
  21. North America Non-Steroidal Anti-Inflammatories Market By Region, From 2019-2024 (USD Million)
  22. North America Mucolytic Market By Region, From 2019-2024 (USD Million)
  23. United States Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  24. United States Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  25. Canada Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  26. Canada Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  27. Europe Bovine Respiratory Disease Treatment Market By Region, From 2019-2024 (USD Million)
  28. Europe Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  29. Europe Anti-Infectious Agents Market By Region, From 2019-2024 (USD Million)
  30. Europe Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  31. Europe Antibiotics Market By Region, From 2019-2024 (USD Million)
  32. Europe Sulfas Market By Region, From 2019-2024 (USD Million)
  33. Europe Anti-Parasiticides Market By Region, From 2019-2024 (USD Million)
  34. Europe Bronchodilators Market By Region, From 2019-2024 (USD Million)
  35. Europe Oral Rehydration Fluids Market By Region, From 2019-2024 (USD Million)
  36. Europe Non-Steroidal Anti-Inflammatories Market By Region, From 2019-2024 (USD Million)
  37. Europe Mucolytic Market By Region, From 2019-2024 (USD Million)
  38. U.K Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  39. U.K Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  40. Spain Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  41. Spain Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  42. Germany Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  43. Germany Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  44. Italy Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  45. Italy Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  46. France Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  47. France Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  48. Asia-Pacific Bovine Respiratory Disease Treatment Market By Region, From 2019-2024 (USD Million)
  49. Asia-Pacific Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  50. Asia-Pacific Anti-Infectious Agents Market By Region, From 2019-2024 (USD Million)
  51. Asia-Pacific Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  52. Asia-Pacific Antibiotics Market By Region, From 2019-2024 (USD Million)
  53. Asia-Pacific Sulfas Market By Region, From 2019-2024 (USD Million)
  54. Asia-Pacific Anti-Parasiticides Market By Region, From 2019-2024 (USD Million)
  55. Asia-Pacific Bronchodilators Market By Region, From 2019-2024 (USD Million)
  56. Asia-Pacific Oral Rehydration Fluids Market By Region, From 2019-2024 (USD Million)
  57. Asia-Pacific Non-Steroidal Anti-Inflammatories Market By Region, From 2019-2024 (USD Million)
  58. Asia-Pacific Mucolytic Market By Region, From 2019-2024 (USD Million)
  59. China Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  60. China Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  61. India Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  62. India Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  63. Japan Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  64. Japan Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  65. South Korea Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  66. South Korea Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  67. Australia Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  68. Australia Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  69. Latin America Bovine Respiratory Disease Treatment Market By Region, From 2019-2024 (USD Million)
  70. Latin America Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  71. Latin America Anti-Infectious Agents Market By Region, From 2019-2024 (USD Million)
  72. Latin America Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  73. Latin America Antibiotics Market By Region, From 2019-2024 (USD Million)
  74. Latin America Sulfas Market By Region, From 2019-2024 (USD Million)
  75. Latin America Anti-Parasiticides Market By Region, From 2019-2024 (USD Million)
  76. Latin America Bronchodilators Market By Region, From 2019-2024 (USD Million)
  77. Latin America Oral Rehydration Fluids Market By Region, From 2019-2024 (USD Million)
  78. Latin America Non-Steroidal Anti-Inflammatories Market By Region, From 2019-2024 (USD Million)
  79. Latin America Mucolytic Market By Region, From 2019-2024 (USD Million)
  80. Brazil Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  81. Brazil Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  82. Argentina Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  83. Argentina Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  84. Mexico Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  85. Mexico Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  86. Middle East & Africa Bovine Respiratory Disease Treatment Market By Region, From 2019-2024 (USD Million)
  87. Middle East & Africa Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  88. Middle East & Africa Anti-Infectious Agents Market By Region, From 2019-2024 (USD Million)
  89. Middle East & Africa Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  90. Middle East & Africa Antibiotics Market By Region, From 2019-2024 (USD Million)
  91. Middle East & Africa Sulfas Market By Region, From 2019-2024 (USD Million)
  92. Middle East & Africa Anti-Parasiticides Market By Region, From 2019-2024 (USD Million)
  93. Middle East & Africa Bronchodilators Market By Region, From 2019-2024 (USD Million)
  94. Middle East & Africa Oral Rehydration Fluids Market By Region, From 2019-2024 (USD Million)
  95. Middle East & Africa Non-Steroidal Anti-Inflammatories Market By Region, From 2019-2024 (USD Million)
  96. Middle East & Africa Mucolytic Market By Region, From 2019-2024 (USD Million)
  97. Middle East Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  98. Middle East Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)
  99. Africa Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2019-2024 (USD Million)
  100. Africa Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2019-2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample